Tapewire

Nasdaq · USD

GNTX

GENTEX CORP

Export transactions ↓
Tapewire entity
3954
SEC CIK
0000355811
Parsed reports
338

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202609
Mar 202600
Apr 202601
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 27, 2021 Filed Jul 28, 2021 18:16 UTC Exercise / conversionNon-Employee Director Stock Option Grant · Derivative 7,000 $0.00 Strike: $24.21 $0.00
Disclosure

SEC source: 0001562180-21-005078 · primarydocument.xml · derivative · entry 3

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2028-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 27, 2021 Filed Jul 28, 2021 18:16 UTC SaleCommon Stock 7,000 $32.65 $228,549.30
Disclosure

SEC source: 0001562180-21-005078 · primarydocument.xml · nonDerivative · entry 2

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,365

F1 · price: This transaction was executed in multiple trades at prices ranging from $32.6475 to $32.655. The price reported above reflects the weighted average price.

Read SEC document
July 27, 2021 Filed Jul 28, 2021 18:16 UTC Exercise / conversionCommon Stock 7,000 $24.21 $169,470.00
Disclosure

SEC source: 0001562180-21-005078 · primarydocument.xml · nonDerivative · entry 1

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 9, 2021 17:24 UTC
Zang LingDirector
SaleCommon Stock 10,000 $34.34 $343,400.00
Disclosure

SEC source: 0001562180-21-004148 · primarydocument.xml · nonDerivative · entry 1

Zang Ling · CIK 0001864245 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,138

Read SEC document
May 21, 2021 Filed May 24, 2021 20:15 UTC SaleCommon Stock 4,061 $34.68 $140,838.73
Disclosure

SEC source: 0001562180-21-003698 · primarydocument.xml · nonDerivative · entry 2

Hollars James A · CIK 0001608435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,149

F2 · price: This transaction was executed in multiple trades at prices ranging from $34.50 to $34.83. The price reported above reflects the weighted average price.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:16 UTC GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003702 · primarydocument.xml · nonDerivative · entry 1

Wallace James H · CIK 0001398852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,709

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:16 UTC GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003700 · primarydocument.xml · nonDerivative · entry 1

Starkoff Kathleen · CIK 0001755126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,309

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:16 UTC GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003701 · primarydocument.xml · nonDerivative · entry 1

WALKER BRIAN C · CIK 0001202922 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,309

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:15 UTC GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003699 · primarydocument.xml · nonDerivative · entry 1

Schaum Richard O · CIK 0001333446 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,869

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:15 UTC GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003698 · primarydocument.xml · nonDerivative · entry 1

Hollars James A · CIK 0001608435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,210

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:14 UTC
GOODE GARY FDirector
GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003697 · primarydocument.xml · nonDerivative · entry 1

GOODE GARY F · CIK 0001223646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,309

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:14 UTC GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003696 · primarydocument.xml · nonDerivative · entry 1

BROWN LESLIE L · CIK 0001674693 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,309

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
May 20, 2021 Filed May 27, 2021 13:49 UTC
Zang LingDirector
GrantCommon Stock 2,845 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-003758 · primarydocument.xml · nonDerivative · entry 1

Zang Ling · CIK 0001864245 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,138

F1 · shares: These shares vest 100% one year from grant award date.

Read SEC document
April 28, 2021 Filed Apr 29, 2021 14:02 UTC Exercise / conversionNon-Employee Director Stock Option Grant · Derivative 12,000 $0.00 Strike: $15.86 $0.00
Disclosure

SEC source: 0001562180-21-003008 · primarydocument.xml · derivative · entry 3

Schaum Richard O · CIK 0001333446 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2021-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 28, 2021 Filed Apr 29, 2021 14:02 UTC SaleCommon Stock 5,440 $35.69 $194,177.54
Disclosure

SEC source: 0001562180-21-003008 · primarydocument.xml · nonDerivative · entry 2

Schaum Richard O · CIK 0001333446 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,024

F1 · price: This transaction was executed in multiple trades at prices ranging from $35.68 to $35.735. The price reported above reflects the weighted average price.

Read SEC document
April 28, 2021 Filed Apr 29, 2021 14:02 UTC Exercise / conversionCommon Stock 12,000 $15.86 $190,260.00
Disclosure

SEC source: 0001562180-21-003008 · primarydocument.xml · nonDerivative · entry 1

Schaum Richard O · CIK 0001333446 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2021 Filed Apr 1, 2021 15:40 UTC
Boehm NeilChief Technology Officer
SaleCommon Stock 2,053 $35.66 $73,217.58
Disclosure

SEC source: 0001562180-21-002503 · primarydocument.xml · nonDerivative · entry 1

Boehm Neil · CIK 0001731934 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,025

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.41 to $35.94. The price reported above reflects the weighted average price.

F3 · balance_after: Column 5 reflects the acquisition of 20 shares under the Gentex Corp. Employee Stock Purchase Plan.

Read SEC document
March 31, 2021 Filed Apr 1, 2021 15:39 UTC
Chiodo MatthewVice President of Sales
SaleCommon Stock 6,851 $35.66 $244,332.01
Disclosure

SEC source: 0001562180-21-002502 · primarydocument.xml · nonDerivative · entry 1

Chiodo Matthew · CIK 0001731933 · Vice President of Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,389

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.41 to $35.94. The price reported above reflects the weighted average price.

F3 · balance_after: Column 5 reflects the acquisition of 406 shares under the Gentex Corp. Employee Stock Purchase Plan.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 19:23 UTC
Ryan Scott PGeneral Counsel
SaleCommon Stock 1,650 $35.57 $58,689.18
Disclosure

SEC source: 0001562180-21-001438 · primarydocument.xml · nonDerivative · entry 1

Ryan Scott P · CIK 0001651517 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,627

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.34 to $35.85. The price reported above reflects the weighted average price.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 19:22 UTC
Downing Steven RPresident and CEO
SaleCommon Stock 6,300 $35.57 $224,085.96
Disclosure

SEC source: 0001562180-21-001437 · primarydocument.xml · nonDerivative · entry 1

Downing Steven R · CIK 0001577379 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,911

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.34 to $35.85. The price reported above reflects the weighted average price.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 19:22 UTC
Nash Kevin CChief Financial Officer
SaleCommon Stock 3,150 $35.57 $112,042.98
Disclosure

SEC source: 0001562180-21-001436 · primarydocument.xml · nonDerivative · entry 1

Nash Kevin C · CIK 0001577359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,313

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.34 to $35.85. The price reported above reflects the weighted average price.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 17:40 UTC
Ryan Scott PGeneral Counsel
GrantCommon Stock 5,552 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001360 · primarydocument.xml · nonDerivative · entry 1

Ryan Scott P · CIK 0001651517 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,277

F1 · shares: These shares vest 100% three years from grant award date.

F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 17:40 UTC
Nash Kevin CChief Financial Officer
GrantCommon Stock 6,345 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001359 · primarydocument.xml · nonDerivative · entry 1

Nash Kevin C · CIK 0001577359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,463

F1 · shares: These shares vest 100% three years from grant award date.

F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 17:39 UTC
Downing Steven RPresident and CEO
GrantCommon Stock 18,327 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001358 · primarydocument.xml · nonDerivative · entry 1

Downing Steven R · CIK 0001577379 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,211

F1 · shares: These shares vest 100% three years from grant award date.

F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 17:38 UTC
Chiodo MatthewVice President of Sales
GrantCommon Stock 6,027 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001357 · primarydocument.xml · nonDerivative · entry 1

Chiodo Matthew · CIK 0001731933 · Vice President of Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,834

F1 · shares: These shares vest 100% three years from grant award date.

F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 17:38 UTC
Boehm NeilChief Technology Officer
GrantCommon Stock 6,456 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-001356 · primarydocument.xml · nonDerivative · entry 1

Boehm Neil · CIK 0001731934 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,058

F1 · shares: These shares vest 100% three years from grant award date.

F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan.

F3 · balance_after: Column 5 reflects the acquisition of 24 shares under the Gentex Corp. Employee Stock Purchase Plan.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 22:11 UTC
Nash Kevin CChief Financial Officer
SaleCommon Stock 2,922 $35.73 $104,412.99
Disclosure

SEC source: 0001562180-21-001216 · primarydocument.xml · nonDerivative · entry 1

Nash Kevin C · CIK 0001577359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,118

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.53 to $35.88. The price reported above reflects the weighted average price.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 19:56 UTC
Ryan Scott PGeneral Counsel
SaleCommon Stock 1,512 $35.73 $54,028.90
Disclosure

SEC source: 0001562180-21-001187 · primarydocument.xml · nonDerivative · entry 1

Ryan Scott P · CIK 0001651517 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,725

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.53 to $35.88. The price reported above reflects the weighted average price.

Read SEC document
February 16, 2021 Filed Feb 17, 2021 20:00 UTC
Downing Steven RPresident and CEO
SaleCommon Stock 6,384 $35.73 $228,122.03
Disclosure

SEC source: 0001562180-21-001188 · primarydocument.xml · nonDerivative · entry 1

Downing Steven R · CIK 0001577379 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,884

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.53 to $35.88. The price reported above reflects the weighted average price.

F3 · balance_after: Column 5 reflects the acquisition of 93 shares under the Gentex Corp. Employee Stock Purchase Plan.

Read SEC document
February 12, 2021 Filed Feb 16, 2021 16:03 UTC
GOODE GARY FDirector
Exercise / conversionNon-Employee Director Stock Option Grant · Derivative 14,000 $0.00 Strike: $14.30 $0.00
Disclosure

SEC source: 0001562180-21-001151 · primarydocument.xml · derivative · entry 3

GOODE GARY F · CIK 0001223646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,000 shares

Expires 2024-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2021 Filed Feb 16, 2021 16:03 UTC
GOODE GARY FDirector
SaleCommon Stock 14,000 $35.59 $498,220.80
Disclosure

SEC source: 0001562180-21-001151 · primarydocument.xml · nonDerivative · entry 2

GOODE GARY F · CIK 0001223646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,464

F1 · price: This transaction was executed in multiple trades at prices ranging from $35.55 to $35.65. The price reported above reflects the weighted average price.

Read SEC document
February 12, 2021 Filed Feb 16, 2021 16:03 UTC
GOODE GARY FDirector
Exercise / conversionCommon Stock 14,000 $14.30 $200,200.00
Disclosure

SEC source: 0001562180-21-001151 · primarydocument.xml · nonDerivative · entry 1

GOODE GARY F · CIK 0001223646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 05, 2021 Filed Feb 8, 2021 22:20 UTC Exercise / conversionNon-Employee Director Stock Option Grant · Derivative 6,133 $0.00 Strike: $17.46 $0.00
Disclosure

SEC source: 0001562180-21-000979 · primarydocument.xml · derivative · entry 3

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,133 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 05, 2021 Filed Feb 8, 2021 22:20 UTC SaleCommon Stock 6,133 $34.81 $213,460.29
Disclosure

SEC source: 0001562180-21-000979 · primarydocument.xml · nonDerivative · entry 2

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,365

F1 · price: This transaction was executed in multiple trades at prices ranging from $34.79 to $34.82. The price reported above reflects the weighted average price.

Read SEC document
February 05, 2021 Filed Feb 8, 2021 22:20 UTC Exercise / conversionCommon Stock 6,133 $17.46 $107,082.18
Disclosure

SEC source: 0001562180-21-000979 · primarydocument.xml · nonDerivative · entry 1

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,498

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 04, 2021 Filed Feb 5, 2021 15:41 UTC Exercise / conversionNon-Employee Director Stock Option Grant · Derivative 7,000 $0.00 Strike: $18.70 $0.00
Disclosure

SEC source: 0001562180-21-000919 · primarydocument.xml · derivative · entry 3

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2027-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 04, 2021 Filed Feb 5, 2021 15:41 UTC SaleCommon Stock 7,000 $34.90 $244,281.10
Disclosure

SEC source: 0001562180-21-000919 · primarydocument.xml · nonDerivative · entry 2

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,365

F1 · price: This transaction was executed in multiple trades at prices ranging from $34.75 to $35.07. The price reported above reflects the weighted average price.

Read SEC document
February 04, 2021 Filed Feb 5, 2021 15:41 UTC Exercise / conversionCommon Stock 7,000 $18.70 $130,900.00
Disclosure

SEC source: 0001562180-21-000919 · primarydocument.xml · nonDerivative · entry 1

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:39 UTC
Chiodo MatthewVice President of Sales
Exercise / conversionEmployee Stock Option (Right to buy) · Derivative 5,000 $0.00 Strike: $15.69 $0.00
Disclosure

SEC source: 0001562180-21-000906 · primarydocument.xml · derivative · entry 3

Chiodo Matthew · CIK 0001731933 · Vice President of Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2021-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:39 UTC
Chiodo MatthewVice President of Sales
SaleCommon Stock 5,000 $33.06 $165,315.50
Disclosure

SEC source: 0001562180-21-000906 · primarydocument.xml · nonDerivative · entry 2

Chiodo Matthew · CIK 0001731933 · Vice President of Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,807

F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $32.89 to $33.41. The price reported above reflects the weighted average price.

F1 · balance_after: Column 5 reflects the acquisition of 209 shares under the Gentex Corp. Employee Stock Purchase Plan.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:39 UTC
Chiodo MatthewVice President of Sales
Exercise / conversionCommon Stock 5,000 $15.69 $78,450.00
Disclosure

SEC source: 0001562180-21-000906 · primarydocument.xml · nonDerivative · entry 1

Chiodo Matthew · CIK 0001731933 · Vice President of Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Column 5 reflects the acquisition of 209 shares under the Gentex Corp. Employee Stock Purchase Plan.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:07 UTC Exercise / conversionNon-Employee Director Stock Option Grant · Derivative 867 $0.00 Strike: $17.46 $0.00
Disclosure

SEC source: 0001562180-21-000899 · primarydocument.xml · derivative · entry 3

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,133

Underlying: Common Stock · 867 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:07 UTC SaleCommon Stock 867 $34.19 $29,638.40
Disclosure

SEC source: 0001562180-21-000899 · primarydocument.xml · nonDerivative · entry 2

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,365

F1 · price: This transaction was executed in multiple trades at prices ranging from $34.165 to $34.215. The price reported above reflects the weighted average price.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:07 UTC Exercise / conversionCommon Stock 867 $17.46 $15,137.82
Disclosure

SEC source: 0001562180-21-000899 · primarydocument.xml · nonDerivative · entry 1

MULDER JOHN A · CIK 0001232671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:02 UTC Exercise / conversionEmployee Stock Option (Right to buy) · Derivative 7,000 $0.00 Strike: $14.30 $0.00
Disclosure

SEC source: 0001562180-21-000898 · primarydocument.xml · derivative · entry 3

Wallace James H · CIK 0001398852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2024-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:02 UTC SaleCommon Stock 7,000 $33.90 $237,286.70
Disclosure

SEC source: 0001562180-21-000898 · primarydocument.xml · nonDerivative · entry 2

Wallace James H · CIK 0001398852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,864

F1 · price: This transaction was executed in multiple trades at prices ranging from $33.82 to $33.94. The price reported above reflects the weighted average sale price.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 18:02 UTC Exercise / conversionCommon Stock 7,000 $14.30 $100,100.00
Disclosure

SEC source: 0001562180-21-000898 · primarydocument.xml · nonDerivative · entry 1

Wallace James H · CIK 0001398852 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2020 Filed Jan 4, 2021 22:26 UTC
Ryan Scott PGeneral Counsel
SaleCommon Stock 1,650 $33.93 $55,989.78
Disclosure

SEC source: 0001562180-21-000049 · primarydocument.xml · nonDerivative · entry 1

Ryan Scott P · CIK 0001651517 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,237

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $33.74 to $34.06. The price reported above reflects the weighted average price.

F3 · balance_after: Column 5 reflects the acquisition of 93 shares under the Gentex Corp. Employee Stock Purchase Plan.

Read SEC document
November 18, 2020 Filed Nov 20, 2020 18:05 UTC
Nash Kevin CChief Financial Officer
Exercise / conversionEmployee Stock Option (Right to buy) · Derivative 5,864 $0.00 Strike: $13.39 $0.00
Disclosure

SEC source: 0001562180-20-006814 · primarydocument.xml · derivative · entry 5

Nash Kevin C · CIK 0001577359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,864 shares

Expires 2021-09-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Options are fully vested.

Read SEC document
November 18, 2020 Filed Nov 20, 2020 18:05 UTC
Nash Kevin CChief Financial Officer
Exercise / conversionEmployee Stock Option (Right to buy) · Derivative 4,836 $0.00 Strike: $15.50 $0.00
Disclosure

SEC source: 0001562180-20-006814 · primarydocument.xml · derivative · entry 4

Nash Kevin C · CIK 0001577359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,836 shares

Expires 2022-09-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Options are fully vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.